AGONOTES: A Robot Annotator for Argonaute Proteins.

AGONOTES: A Robot Annotator for Argonaute Proteins.

Argonaute protein (Ago) exists in almost all organisms. In eukaryotes, functions as a system for the regulation of gene expression. In prokaryotes, it is a kind of defense against invasive alien genome. Ago system has been engineered to silence genes and genome editing and play an important role in biological studies.

With an increasing number of genomes and proteomes of various microbes become available, computational tools to identify and annotating argonaute protein is needed. We introduce AGONOTES (Argonaute Note). This is a web service designed specifically for identifying and annotating Ago. AGONOTES using BLASTP similarity search algorithm to categorize all proteins are delivered into three groups: argonaute prokaryotic protein (Pago), argonaute eukaryotic proteins (EAGO), and non-argonaute protein (non-Ago).

Argonaute proteins can then be adjusted to match the standard set Ago sequence using the program MUSCLE multiple sequence alignment. All functional domains can be further Ago curated from the alignment and visualized easily through the module Bio :: Graphic in bundles BioPerl. Compared with the existing tools such as CD-Search and the available databases such as UniProt and AGONOTES show much better performance on domain explanation, which is the basis for studying the new Ago. AGONOTES freely accessible in https://i.uestc.edu.cn/agonotes/. AGONOTES is a friendly tool for annotating Ago domain of the proteome, or a series of protein sequences.


Tuning the molecular and electronic properties of Pt (II) complex -organic have profound effects on their application in the fields of technology, medicine and engineering crystals. Here, we present a combination of infrared and Raman spectroscopic investigations on trans-PtCl2 (PEt3) 2 systematically carried out at various temperatures from 300 to 4.2 K in various spectral. Studies suggest orientational change drastically different from the group at around 180 K and 130 K in the group of ligands bound to the central Pt atom. This is accompanied by systematic strengthening of hydrogen bonds C-H ⋯ Cl in the temperature range 180-130 K.

 AGONOTES: A Robot Annotator for Argonaute Proteins.
AGONOTES: A Robot Annotator for Argonaute Proteins.

T-Pro MycoClean spray

JT90-R002 500ml/BT
EUR 172.8

T-Pro EZ Gel Solution 8%

JB02-B008M 500ml/BT
EUR 266.4

T-Pro EZ Gel Solution 8%

JB02-B008S 100ml/BT
EUR 162

T-Pro EZ Gel Solution 10%

JB02-B010M 500ml/BT
EUR 266.4

T-Pro EZ Gel Solution 10%

JB02-B010S 100ml/BT
EUR 162

T-Pro EZ Gel Solution 12%

JB02-B012M 500ml/BT
EUR 266.4

T-Pro EZ Gel Solution 12%

JB02-B012S 100ml/BT
EUR 162

T-Pro EZ Gel Solution 15%

JB02-B015M 500ml/BT
EUR 266.4

T-Pro EZ Gel Solution 15%

JB02-B015S 100ml/BT
EUR 162

T-Pro Separating or Resolving Buffer

JB03-C001 500ml/BT
EUR 182.4

T-Pro BCA Protein Assay kit

JB04-D001 500assay/KIT
EUR 244.8

T-Pro Transfer Blotting buffer (10X)

JB08-H001 500ml/BT
EUR 162

T-Pro Western Blot Stripping Reagent

JB11-K002 500ml/BT
EUR 213.6

T-Pro Aqua EZ Clean (M)

JT90-R001M 500ml/BT
EUR 398.4

T-Pro Aqua EZ Clean (S)

JT90-R001S 100ml/BT
EUR 181.2

T-Pro EZ stain Gel solution

JT90-R005M 500ml/BT
EUR 224.4

T-Pro EZ stain Gel solution

JT90-R005S 100ml/BT
EUR 151.2

T-Pro P-Fect Transfection Reagent

JT97-N005M 1.0ml/vial
EUR 266.4

T-Pro Plasmid Mini Kit (100)

RB94-YPD100 100preps/Kit
EUR 193.2

T-Pro Plasmid Mini Kit (250)

RB94-YPD250 250preps/Kit
EUR 266.4

T-Pro Plasmid Midi Kit (20)

RB94-YPI020 20preps/Kit
EUR 255.6

T-Pro Plasmid Maxi Kit (10)

RB94-YPM010 10preps/Kit
EUR 266.4

T-Pro BCA Protein Assay Reagent A

JB04-D001A 500ml/BT
EUR 204

T-Pro BCA Protein Assay Reagent B

JB04-D001B 12ml/BT
EUR 140.4

T-Pro Bradford Protein Assay kit(1X)

JB04-D002 500ml/BT
EUR 193.2

T-Pro Fast Blocking Buffer (in PBS)

JK92-W001 500ml/BT
EUR 224.4

T-Pro Fast Blocking Buffer (in TBS)

JK92-W002 500ml/BT
EUR 224.4

T-Pro Genomic DNA Midi Kit (20)

RB94-NGM020 20preps/kit
EUR 266.4

T-Pro Genomic DNA Mini Kit (100)

RB94-NGS100 100preps/kit
EUR 255.6

T-Pro Laemmli (SDS sample) Reagent (reducing 4X)

JB06-F002 10ml/BT
EUR 151.2

T-Pro Tris-Glycine-SDS running buffer (10X)

JB07-G001 500ml/BT
EUR 162

T-Pro Tris-Glycine-Native running buffer (10X)

JB07-G002 500ml/BT
EUR 162

T-Pro Semi Dry Transfer Blotting buffer (10X)

JB08-H002 500ml/BT
EUR 172.8

T-Pro Protein Free Blocking Buffer (in PBS)

JK92-W003 500ml/BT
EUR 224.4

T-Pro Protein Free Blocking Buffer (in TBS)

JK92-W004 500ml/BT
EUR 224.4

T-Pro Nonliposomal Transfection Reagent I (NTR I)

JT97-N001M 1.0ml/vial
EUR 224.4

T-Pro Nonliposomal Transfection Reagent II (NTR II)

JT97-N002M 1.0ml/vial
EUR 244.8

T-Pro Nonliposomal Transfection Reagent III (NTR III)

JT97-N006M 1.0ml/vial
EUR 266.4

T-Pro Endotoxin Removal Plasmid Midi kit (25)

RB94-EPI020 20preps/Kit
EUR 297.6

T-Pro Endotoxin Removal Plasmid Maxi kit (10)

RB94-EPM010 10preps/Kit
EUR 318

T-Pro Plant Genomic DNA Midi Kit (20)

RB94-PGM020 20preps/kit
EUR 266.4

T-Pro Plant Genomic DNA Mini Kit (100)

RB94-PGS100 100preps/kit
EUR 266.4

T-Pro Laemmli (SDS sample) Reagent (non-reducing 4X)

JB06-F003 10ml/BT
EUR 151.2

T-Pro LumiFast Plus Chemiluminescence Detection Kit (ECL Kit)

JT96-K002M 250ml*2/Kit
EUR 244.8

T-Pro LumiFast Plus Chemiluminescence Detection Kit (ECL Kit)

JT96-K002S 100ml*2/Kit
EUR 182.4

T-Pro LumiLong Plus Chemiluminescence Detection Kit (ECL Kit)

JT96-K004M 250ml*2/Kit
EUR 286.8

T-Pro LumiLong Plus Chemiluminescence Detection Kit (ECL Kit)

JT96-K004S 100ml*2/Kit
EUR 204

T-Pro Gel/PCR DNA Purification Maxi Kit (10)

RB94-NEL010 10preps/Kit
EUR 193.2

T-Pro Gel/PCR DNA Purification Mini Kit (100)

RB94-NES100 100preps/Kit
EUR 193.2

T-Pro Gel/PCR DNA Purification Mini Kit (250)

RB94-NES250 250preps/Kit
EUR 266.4

T-Pro Washing buffer in PBS and Tween-20 (10X)

JB09-I003 500ml/BT
EUR 172.8

T-Pro Washing buffer in TBS and Tween-20 (10X)

JB09-I004 500ml/BT
EUR 172.8

T-Pro Phosphate-Buffered Saline (PBS, 10X) for western blot washing

JB09-I001 500ml/BT
EUR 162

T-Pro Tris-Buffered Saline (TBS, 10X) for western blot washing

JB09-I002 500ml/BT
EUR 162

Untransduced T Cells

78170-1 1 vial
EUR 1250
Description: The untransduced T cells are produced by mock lentiviral transduction of human primary CD4+CD8+ T cells. These cells are subjected to comparable manipulations as CAR-T cells: activation, spinoculation (without lentivirus), and expansion. These T cells are meant to be negative controls in experiments using lentivirus-transduced primary CAR-T cells.

Untransduced T Cells

78170-2 5 vials
EUR 3325
Description: The untransduced T cells are produced by mock lentiviral transduction of human primary CD4+CD8+ T cells. These cells are subjected to comparable manipulations as CAR-T cells: activation, spinoculation (without lentivirus), and expansion. These T cells are meant to be negative controls in experiments using lentivirus-transduced primary CAR-T cells.

CD4+ T cells, Negatively Selected (Human)

79752 10 million cells
EUR 395
Description: Cryopreserved vial (10 x 10^6 cells) of CD4+ T cells that were negatively selected from freshly isolated primary human peripheral blood mononuclear cells (PBMCs). The PBMCs came from a healthy donor, and were isolated from whole blood or leukapheresis samples using a Ficoll gradient. Magnetic antibodies to monocytes, granulocytes, CD8+ T cells, gamma/delta T cells and other immune subsets present in PBMCs were then used to purify untouched CD4+ T cells via immunomagnetic separation. Before and after CD4+ T cell isolation, the cells were stained to evaluate purity and viability by flow cytometry. Cells were cryopreserved in CryoStor CS10 cryopreservation medium (Stemcell, #07930) at a controlled rate._x000D_Source
Normal human PBMC from Leukapheresis Sample

CD8+ T cells, Negatively Selected (Human)

79753 10 million cells
EUR 495
Description: Cryopreserved vial (10 x 10^6 cells) of CD8+ T cells that were negatively selected from freshly isolated primary human peripheral blood mononuclear cells (PBMCs). The PBMCs came from a healthy donor, and were isolated from whole blood or leukapheresis samples using a Ficoll gradient. Magnetic antibodies to monocytes, granulocytes, CD4+ T cells, gamma/delta T cells and other immune subsets present in PBMCs were then used to purify untouched CD8+ T cells via immunomagnetic separation. Before and after CD8+ T cell isolation, the cells were stained to evaluate purity and viability by flow cytometry. Cells were cryopreserved in CryoStor CS10 cryopreservation medium (Stemcell, #07930) at a controlled rate._x000D_Source
Normal human PBMC from Leukapheresis Sample

Anti-CD19 CAR-T Cells

78171-1 1 vial
EUR 1595
Description: The anti-CD19 CAR-T cells are produced by high-titer lentiviral transduction of human primary CD4+CD8+ T cells using the anti-CD19 CAR Lentivirus (CD19 ScFv-CD8-4-1BB-CD3ζ; SIN Vector, BPS Bioscience, #78601). These ready-to use CAR-T cells express an anti-CD19 CAR consisting the ScFv of CD19 (clone FMC63) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains. These CAR-T cells have been validated using flow cytometry (to determine the CAR expression) and co-culture cytotoxicity assays.

Anti-CD19 CAR-T Cells

78171-2 5 vials
EUR 4250
Description: The anti-CD19 CAR-T cells are produced by high-titer lentiviral transduction of human primary CD4+CD8+ T cells using the anti-CD19 CAR Lentivirus (CD19 ScFv-CD8-4-1BB-CD3ζ; SIN Vector). These ready-to use CAR-T cells express an anti-CD19 CAR consisting the ScFv of CD19 (clone FMC63) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains.These CAR-T cells have been validated using flow cytometry (to determine the CAR expression) and co-culture cytotoxicity assays.

Anti-BCMA CAR-T Cells

78660-1 1 vial
EUR 1595
Description: The anti-BCMA CAR-T cells are produced by high-titer lentiviral transduction of human primary CD4+CD8+ T cells using the anti-BCMA CAR Lentivirus (BPS Bioscience #78655). These ready-to-use CAR-T cells express an anti-BCMA CAR consisting of the ScFv of BCMA (clone C11D5.3) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains (Figure 1). These CAR-T cells have been validated using flow cytometry (to determine the CAR expression) and co-culture cytotoxicity assays.

Anti-BCMA CAR-T Cells

78660-2 5 vials
EUR 4250
Description: The anti-BCMA CAR-T cells are produced by high-titer lentiviral transduction of human primary CD4+CD8+ T cells using the anti-BCMA CAR Lentivirus (BPS Bioscience #78655). These ready-to-use CAR-T cells express an anti-BCMA CAR consisting of the ScFv of BCMA (clone C11D5.3) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains (Figure 1). These CAR-T cells have been validated using flow cytometry (to determine the CAR expression) and co-culture cytotoxicity assays.

anti-CD4 T helper cells

502-A-01mg 0,1 mg
EUR 321
Description: anti-CD4 T helper cells

anti-CD4 T helper cells

502-A-1000ug 1000 ug
EUR 1539
Description: anti-CD4 T helper cells

anti-CD4 T helper cells

502-A-100ugvial 100 ug/vial
EUR 150
Description: anti-CD4 T helper cells

anti-CD8 T cytotoxic/supressor cells

505-A-01mg 0,1 mg
EUR 321
Description: anti-CD8 T cytotoxic/supressor cells

anti-CD8 T cytotoxic/supressor cells

505-A-1000ug 1000 ug
EUR 1539
Description: anti-CD8 T cytotoxic/supressor cells

anti-CD8 T cytotoxic/supressor cells

505-A-100ugvial 100 ug/vial
EUR 150
Description: anti-CD8 T cytotoxic/supressor cells

Human Normal Peripheral Blood CD4+/CD25+ Regulatory T Cells (T reg), Fresh

PBCD4-25-F2M - Ask for price

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNC942884-100 100uL
EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF594 conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNC942884-500 500uL
EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF594 conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNC802884-100 100uL
EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF680 conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNC802884-500 500uL
EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF680 conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNC702884-100 100uL
EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF770 conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNC702884-500 500uL
EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF770 conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNC882884-100 100uL
EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF488A conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNC882884-500 500uL
EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF488A conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNC812884-100 100uL
EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF680R conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNC812884-500 500uL
EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF680R conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNC402884-100 100uL
EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF640R conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNC402884-500 500uL
EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF640R conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNC052884-100 100uL
EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF405M conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNC052884-500 500uL
EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF405M conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNC042884-100 100uL
EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF405S conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNC042884-500 500uL
EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF405S conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNCAP2884-100 100uL
EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNCAP2884-500 500uL
EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNCA2884-250 250uL
EUR 472.8
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), APC conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNCP2884-250 250uL
EUR 472.8
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), PerCP conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNCR2884-250 250uL
EUR 472.8
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), RPE conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNCH2884-100 100uL
EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNCH2884-500 500uL
EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNCB2884-100 100uL
EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Biotin conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNCB2884-500 500uL
EUR 654
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Biotin conjugate, Concentration: 0.1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNUB2884-100 100uL
EUR 316.8
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Concentration: 0.2mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNUB2884-50 50uL
EUR 486
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), 1mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNUB2884-500 500uL
EUR 615.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Concentration: 0.2mg/mL

CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody

BNC472884-100 100uL
EUR 279.6
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF647 conjugate, Concentration: 0.1mg/mL

 

Tumor-derived extracellular vesicles: insight observer effect of exosomes after irradiation.

This review article aims to overcome the kinetic of TDES on cancer cells pre and post-radiotherapy. Radiotherapy is traditionally used for the treatment of some types of cancer; However, there is growing evidence indicates that radiotherapy NTEs exerts on cells close to irradiated cells. In the tumor mass, the cells were irradiated may affect the cells in the non-irradiated in a different way.

Of note, exosomes are nano-scale particles release cells from tumor cells and play a key role in the survival, metastasis and tumor cell immunosuppression. Recent evidence suggests that irradiation has the potential to affect the dynamics of the different signaling pathways such as the exosome biogenesis. Indeed, exosomes act as a mediator between the various cell communication through the transmission of bio-molecules. Because of their important role in cancer biology, exosomes are in the limelight. TDES contains proprietary molecular signatures that they can function as a tumor biomarker in cancer diagnosis is different.

anti-IgM Heavy chain expressed on B cells

522-A-01mg 0,1 mg
EUR 321
Description: anti-IgM Heavy chain expressed on B cells

anti-IgM Heavy chain expressed on B cells

522-A-1000ug 1000 ug
EUR 1539
Description: anti-IgM Heavy chain expressed on B cells

anti-IgM Heavy chain expressed on B cells

522-A-100ugvial 100 ug/vial
EUR 150
Description: anti-IgM Heavy chain expressed on B cells

5637 cells

C0002001 One Frozen vial
EUR 582

FO cells

C0003017 One Frozen vial
EUR 582

K1 cells

C0025003 One Frozen vial
EUR 792

RD cells

C0035001 One Frozen vial
EUR 546

A9 cells

P0011007 One Frozen vial
EUR 651.6

BJ cells

P0020005 One Frozen vial
EUR 546

ST cells

P0028002 One Frozen vial
EUR 651.6

RS4;11 cells

C0003012 One Frozen vial
EUR 546

REH cells

C0003031 One Frozen vial
EUR 582

4T1 cells

C0006004 One Frozen vial
EUR 546

T84 cells

C0009008 One Frozen vial
EUR 546

RKO cells

C0009012 One Frozen vial
EUR 546

H23 cells

C0016005 One Frozen vial
EUR 546

H69 cells

C0016065 One Frozen vial
EUR 546

H82 cells

C0016066 One Frozen vial
EUR 546

A10.7 cells

C0018006 One Frozen vial
EUR 792

C32 cells

C0020002 One Frozen vial
EUR 546

N87 cells

C0023002 One Frozen vial
EUR 546

AGS cells

C0023004 One Frozen vial
EUR 546

R2C cells

C0028001 One Frozen vial
EUR 651.6

Y79 cells

C0029001 One Frozen vial
EUR 546

NB3 cells

C0033003 One Frozen vial
EUR 792

STO cells

P0011006 One Frozen vial
EUR 546

TM3 cells

T0028002 One Frozen vial
EUR 546

anti-Transferrin receptor on activated T-B- cells

518-A-01mg 0,1 mg
EUR 321
Description: anti-Transferrin receptor on activated T-B-, cells

anti-Transferrin receptor on activated T-B- cells

518-A-1000ug 1000 ug
EUR 1539
Description: anti-Transferrin receptor on activated T-B-, cells

anti-Transferrin receptor on activated T-B-, cells

518-A-100ugvial 100 ug/vial
EUR 150
Description: anti-Transferrin receptor on activated T-B-, cells

MB49 cells

C0002004 One Frozen vial
EUR 932.4

K562 cells

C0003004 One Frozen vial
EUR 546

U937 cells

C0003005 One Frozen vial
EUR 546

Raji cells

C0003009 One Frozen vial
EUR 546

BJAB cells

C0003016 One Frozen vial
EUR 651.6

Mino cells

C0003033 One Frozen vial
EUR 582

B103 cells

C0005003 One Frozen vial
EUR 932.4

T47D cells

C0006001 One Frozen vial
EUR 546

HeLa cells

C0008001 One Frozen vial
EUR 546

SiHa cells

C0008002 One Frozen vial
EUR 546

C33A cells

C0008003 One Frozen vial
EUR 546

LoVo cells

C0009011 One Frozen vial
EUR 546

SW48 cells

C0009014 One Frozen vial
EUR 546

H716 cells

C0009022 One Frozen vial
EUR 651.6

OE33 cells

C0013003 One Frozen vial
EUR 792

A549 cells

C0016002 One Frozen vial
EUR 546

H460 cells

C0016003 One Frozen vial
EUR 546

A427 cells

C0016004 One Frozen vial
EUR 546

H520 cells

C0016010 One Frozen vial
EUR 546

H226 cells

C0016011 One Frozen vial
EUR 546

H358 cells

C0016016 One Frozen vial
EUR 546

H441 cells

C0016019 One Frozen vial
EUR 546

H596 cells

C0016020 One Frozen vial
EUR 546

H526 cells

C0016052 One Frozen vial
EUR 546

H446 cells

C0016054 One Frozen vial
EUR 651.6

H187 cells

C0016061 One Frozen vial
EUR 546

H209 cells

C0016063 One Frozen vial
EUR 546

H847 cells

C0016067 One Frozen vial
EUR 651.6

H660 cells

C0016068 One Frozen vial
EUR 834

A673 cells

C0016074 One Frozen vial
EUR 546

H524 cells

C0016077 One Frozen vial
EUR 651.6

H211 cells

C0016078 One Frozen vial
EUR 651.6

H146 cells

C0016080 One Frozen vial
EUR 546

H889 cells

C0016081 One Frozen vial
EUR 651.6

H128 cells

C0016083 One Frozen vial
EUR 651.6

Vcap cells

C0019001 One Frozen vial
EUR 546

8505C cells

C0025002 One Frozen vial
EUR 792

BeWo cells

C0030001 One Frozen vial
EUR 546

HASM cells

P0001001 One Frozen vial
EUR 932.4

HBSM cells

P0007001 One Frozen vial
EUR 932.4

SCBN cells

P0010001 One Frozen vial
EUR 651.6

L929 cells

P0011012 One Frozen vial
EUR 546

VERO cells

P0014002 One Frozen vial
EUR 546

MDCK cells

P0014003 One Frozen vial
EUR 546

C127 cells

S0006001 One Frozen vial
EUR 582

Hs27 cells

T0020010 One Frozen vial
EUR 546

Daudi cells

C0003010 One Frozen vial
EUR 546

MC116 cells

C0003021 One Frozen vial
EUR 582

U87MG cells

C0005002 One Frozen vial
EUR 546

CaSKi cells

C0008004 One Frozen vial
EUR 546

SW480 cells

C0009001 One Frozen vial
EUR 546

SW620 cells

C0009002 One Frozen vial
EUR 546

HCT15 cells

C0009010 One Frozen vial
EUR 546

Hep3B cells

C0015001 One Frozen vial
EUR 546

HepG2 cells

C0015002 One Frozen vial
EUR 546

Calu3 cells

C0016001 One Frozen vial
EUR 546

H1703 cells

C0016008 One Frozen vial
EUR 651.6

H1975 cells

C0016013 One Frozen vial
EUR 651.6

H1650 cells

C0016015 One Frozen vial
EUR 651.6

Interestingly, radiotherapy and IR can also contribute to change the dynamics of exosome secretion. Most likely, the contents of exosomes in irradiated cells was different than the exosomes derived from non-irradiated BCs. irradiated cells release exosomes with exclusive content NTEs mediate in BC. Given the variation in cell type, dose IR, and radio-resistance or radio-sensitivity of different cancers, there is, however, a contradiction in exosomes irradiation features and activities on neighboring cells.

Leave a Reply

Your email address will not be published.